Phase III Clinical Study to Evaluate the Efficacy and Safety of the Combination of Lercanidipine/Valsartan in Hypertensive Patients
Clinical trial NCT01928628 · COMPLETED
Trial details
- NCT number
- NCT01928628
- Sponsor
- LG Life Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-01
- Primary completion
- 2013-04-01
- Enrollment
- 449
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.